Warnings From Analysts Truth: Hidden Jobs Risks Ahead
A stronger-than-expected May jobs report masks deeper tensions. Three warnings from analysts lay out the hidden risks...
Learn effective ways to use your reward points to get the most out of your credit card benefits. Start maximizing your rewards now!
23,429 articlesA stronger-than-expected May jobs report masks deeper tensions. Three warnings from analysts lay out the hidden risks...
EdgeClear steps up in 2026 with a major platform upgrade and lower costs. This edgeclear review 2026 examines whether...
Netflix’s ad-supported tier is gaining traction and subscribers are rising, even as the broader market spurs a debate...
Micron Technology posted a strong quarter but faced a sharp pullback as investors priced in a tougher near-term path....
Shiba Inu’s key on-chain metric has dropped to a five-year low, signaling caution but also a possible setup for a fut...
UBS raises Nucor to Buy with a $190 target after a pullback, highlighting stronger than expected Q1 guidance and impr...
Investors are focused on a pivotal point in the Iran deal: how verification and enforcement are managed as sanctions ...
Barclays lifts Phathom Pharmaceuticals to Overweight with an $18 target, citing a stronger 2026 revenue trajectory an...
AMD has ridden a steep year-to-date surge powered by AI and cloud demand. Analysts warn the rally faces hurdles, but ...
As Zymeworks gears up for 2026 earnings, investors should focus on cash runway, pipeline milestones, and collaboratio...
Investors weigh a bold forecast that Eli Lilly could hit $1,200 by year-end 2026, betting on GLP-1 drugs and a robust...
A noted market analyst warns that Strategy’s aggressive Bitcoin purchases echo dot-com-era speculation, risking a ste...